BeStock  

Mesa Laboratories MLAB

US equityMarket cap rank #3480Scientific & Technical Instruments
$129.96 −$6.10 (-4.48%)
Pre-market · Oct 8, 8:10 am ET · After hours $130.00 +0.03%
Open$133.50
Prev close$136.06
Day range$129.73 – $135.35
Volume70.4K
Market cap$727.24M
P/E (TTM)152.9
Dividend yield0.49%

Fundamentals

Latest reported quarter: Q1, ended Jun 2026

Revenue$60.14M+1.0% YoY
Operating profit$7.03M+129.5% YoY
Net profit$2.83M-40.3% YoY
Diluted EPS$0.49-42.4% YoY
Free cash flow$14.18M+1,503.7% YoY
Operating cash flow$14.74M

Revenue, last 8 quarters

$57.8MSep '24$62.8MDec '24$62.1MMar '25$59.5MJun '25$60.7MSep '25$65.1MDec '25$63.7MMar '26$60.1MJun '26

Net profit, last 8 quarters

$3.4MSep '24$-1.7MDec '24$-7.1MMar '25$4.7MJun '25$2.5MSep '25$3.6MDec '25$-4.1MMar '26$2.8MJun '26

Diluted EPS by quarter

0.63Sep '24-0.31Dec '24-1.31Mar '250.85Jun '250.45Sep '250.65Dec '25-0.75Mar '260.49Jun '26

Free cash flow by quarter

$3.5MSep '24$17.3MDec '24$11.7MMar '25$884.0KJun '25$7.1MSep '25$18.0MDec '25$13.5MMar '26$14.2MJun '26

Annual revenue

$133.9MFY21$184.3MFY22$219.1MFY23$216.2MFY24$241.0MFY25$249.1MFY26

Profitability & balance sheet

Gross margin64.2%
Operating margin9.0%
Net margin1.9%
Return on equity2.7%
Return on assets1.1%
Return on invested capital3.2%
Current ratio1.79
Liabilities / assets55.0%
Cash & investments$30.70M
Total debt$142.87M
Net cash (debt)-$112.17M
Free cash flow / sales21.2%

Where the revenue comes from

Quarter 2027/Q1

By business line

  • Sterilization and Disinfection Control$24.51M 40.7%
  • Calibration Solutions$13.29M 22.1%
  • Biopharmaceutical Development$12.06M 20.1%
  • Clinical Genomics$10.29M 17.1%

Income statement

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Revenue as Reported $60.14M $249.13M $63.72M $65.13M $60.74M
Total Operating Revenue $60.14M $249.13M $63.72M $65.13M $60.74M
Cost of Revenue $21.13M $90.86M $21.52M $23.33M $23.41M
Gross Profit $39.01M $158.27M $42.21M $41.80M $37.33M
Operating Expense $31.98M $139.76M $39.46M $33.82M $32.61M
Selling and Admin Expenses $27.26M $119.45M $34.21M $28.79M $27.56M
-Selling & Marketing Expense $9.87M $40.79M $10.08M $9.99M $9.80M
-General & Admin Expense $17.38M $78.66M $24.13M $18.81M $17.76M
Research & Development $4.73M $20.31M $5.25M $5.03M $5.05M
Operating Profit $7.03M $18.51M $2.75M $7.98M $4.72M
Net Non-Operating Interest Income (Expense) -$2.36M -$10.69M -$2.60M -$3.04M -$2.86M
Non-Operating Interest Expense $2.36M $10.69M $2.60M $3.04M $2.86M
Other Income (Expense) -$315,000.00 $4.20M -$1.75M -$343,000.00 $137,000.00
Other Non-Operating Income (Expenses) -$315,000.00 $4.20M -$1.75M -$343,000.00 $137,000.00
Pretax Profit $4.35M $12.01M -$1.59M $4.60M $2.00M
Tax $1.52M $5.30M $2.54M $966,000.00 -$477,000.00
Net Profit $2.83M $6.71M -$4.14M $3.63M $2.48M
Profit from Continuing Operations $2.83M $6.71M -$4.14M $3.63M $2.48M
Net Income to Parent Company $2.83M $6.71M -$4.14M $3.63M $2.48M
Net Income to Common Stockholders $2.83M $6.71M -$4.14M $3.63M $2.48M
Basic EPS $0.50 $1.22 -$0.75 $0.66 $0.45
Diluted EPS $0.49 $1.21 -$0.75 $0.65 $0.45
Dividend Per Share $0.16 $0.64 $0.16 $0.16 $0.16
Special Income (Charges) – $0.00 $0.00 $0.00 $0.00
-Less:Impairment of Capital Assets – $0.00 – – –

Balance sheet

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Total Assets $419.22M $427.75M $427.75M $434.85M $430.35M
Total Current Assets $102.85M $106.27M $106.27M $105.63M $97.43M
Cash and Cash Equivalents & Short-Term Investments $30.70M $26.93M $26.93M $28.98M $20.42M
-Cash and Cash Equivalents $30.70M $26.93M $26.93M $28.98M $20.42M
Receivables $34.41M $44.10M $44.10M $40.23M $40.09M
-Accounts Receivable $34.41M $44.10M $44.10M $40.23M $40.09M
Prepaid Assets $6.04M $5.25M $5.25M $5.93M $5.59M
Inventory $27.23M $26.37M $26.37M $26.56M $27.74M
Other Current Assets $4.48M $3.62M $3.62M $3.93M $3.59M
Total Non-Current Assets $316.38M $321.48M $321.48M $329.22M $332.92M
Net PPE $30.09M $30.61M $30.61M $31.60M $31.84M
-Gross PPE $61.20M $60.73M $60.73M $61.50M $60.61M
-Accumulated Depreciation -$31.11M -$30.12M -$30.12M -$29.90M -$28.78M
Goodwill and Other Intangible Assets $264.44M $270.21M $270.21M $278.95M $281.76M
-Goodwill $186.04M $186.86M $186.86M $189.30M $188.49M
-Other Intangible Assets $78.40M $83.35M $83.35M $89.65M $93.27M
Non-Current Deferred Assets $1.49M $1.50M $1.50M $1.47M $1.47M
Other Non-Current Assets $20.36M $19.16M $19.16M $17.20M $17.86M
Total Liabilities $230.46M $241.50M $241.50M $248.16M $251.88M
Total Current Liabilities $57.32M $61.90M $61.90M $54.40M $48.30M
Payables $32.28M $35.63M $35.63M $28.35M $23.07M
-Accounts Payable $7.46M $4.93M $4.93M $5.25M $5.09M
-Total Tax Payable $14.58M $14.01M $14.01M $11.53M $9.76M
-Other Payable $10.24M $16.69M $16.69M $11.58M $8.23M
Current Accrued Expenses $2.27M $2.23M $2.23M $2.44M $2.46M
Short-Term Debt and Capital Lease Obligation $8.26M $9.31M $9.31M $9.05M $8.50M
-Current Debt $5.63M $5.63M $5.63M $5.16M $4.69M
-Current Capital Lease Obligation $2.63M $3.69M $3.69M $3.89M $3.82M
Current Deferred Liabilities $14.52M $14.72M $14.72M $14.56M $14.26M
Total Non-Current Liabilities $173.14M $179.60M $179.60M $193.76M $203.59M
Long Term Debt and Capital Lease Obligation $137.24M $145.86M $145.86M $171.93M $181.93M
-Long Term Debt $137.24M $145.86M $145.86M $160.97M $170.16M
Non-Current Deferred Liabilities $20.05M $20.09M $20.09M $21.83M $21.66M
Other Non-Current Liabilities $15.85M $13.66M $13.66M – –
Total Equity $188.76M $186.25M $186.25M $186.69M $178.47M
Stockholders' Equity $188.76M $186.25M $186.25M $186.69M $178.47M
Capital Stock $376.75M $375.35M $375.35M $368.56M $365.17M
-Common Stock $376.75M $375.35M $375.35M $368.56M $365.17M
Retained Earnings -$183.80M -$185.75M -$185.75M -$180.73M -$183.47M
Gains/Losses Not Affecting Retained Earnings -$4.19M -$3.36M -$3.36M -$1.14M -$3.23M
-Long Term Capital Lease Obligation – – – $10.96M $11.76M

Cash flow

Line item 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
Operating Cash Flow $14.74M $42.83M $13.96M $18.75M $8.22M
Net cash flow from continuing operations $14.74M $42.83M $13.96M $18.75M $8.22M
Net Income from Continuing Operations $2.83M $6.71M -$4.14M $3.63M $2.48M
Gain/Loss from Continuing Operations $354,000.00 – – $281,000.00 -$95,000.00
Depreciation & Depletion & Amortization $5.65M $23.27M $5.75M $5.72M $5.85M
Other Non-Cash Items $623,000.00 $1.26M -$2.88M $1.26M $1.63M
Change in Working Capital $2.93M -$4.99M $3.93M $4.48M -$5.45M
-Change in Receivables $9.78M -$3.21M -$4.13M -$819,000.00 -$1.70M
-Change in Inventory -$1.53M -$4.43M -$974,000.00 $596,000.00 -$766,000.00
-Change in Prepaid Assets -$2.28M $608,000.00 $2.15M -$715,000.00 $1.61M
-Change in Payables and Accrued Expense -$2.87M $2.30M $6.62M $5.18M -$3.79M
-Change In Other Working Capital -$171,000.00 -$255,000.00 $259,000.00 $244,000.00 -$813,000.00
Net cash flow from investing -$559,000.00 -$3.25M -$417,000.00 -$732,000.00 -$1.09M
Net Cash Flow from Continuing Investing Activities -$559,000.00 -$3.25M -$417,000.00 -$732,000.00 -$1.09M
Net PPE Purchase and Sale -$559,000.00 -$3.25M -$417,000.00 -$732,000.00 -$1.09M
Financing Cash Flow -$10.50M -$41.85M -$15.76M -$9.79M -$7.88M
Net Cash Flow from Continuing Financing Activities -$10.50M -$41.85M -$15.76M -$9.79M -$7.88M
Net Issuance Payments Of Debt -$8.66M -$26.75M -$14.69M -$8.69M -$6.44M
Cash Dividends Paid -$884,000.00 -$3.52M -$884,000.00 -$884,000.00 -$882,000.00
Net Other Financing Charges -$958,000.00 -$11.58M -$188,000.00 -$214,000.00 -$564,000.00
Ending Cash Balance $30.70M $26.93M $26.93M $28.98M $20.42M
Net Change in Cash $3.68M -$2.27M -$2.21M $8.24M -$753,000.00
Beginning Cash Balance $26.93M $27.32M $28.98M $20.42M $21.28M
Effect of Exchange Rate Changes $88,000.00 $1.88M $167,000.00 $316,000.00 -$104,000.00
Free Cash Flow $14.18M $39.58M $13.55M $18.02M $7.13M
Deferred Tax – -$1.29M – – –
Net Intangibles Purchase and Sale – $0.00 – – –
Net Business Purchase and Sale – $0.00 – – –
Proceeds from Stock Option Exercised – $0.00 – – –

Discussion

No comments yet — be the first to weigh in on MLAB.

Leave a comment

Scroll to Top